Interestingly, Figure 4d shows that functional disruption of TTK expression had no effect on the subcellular localization of c-Abl, suggesting that c-Abl activation in a TTK-null background stimulates pathways that are distinct from its tumor suppressing functions that arise in the nucleus (Supplementary Figure S2). The gene discussed is ABL1; the disease is neoplasm.